Literature DB >> 27093983

[Chinese expert consensus on the diagnosis and treatment of polycythemia vera (2016)].

.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27093983     DOI： 10.3760/cma.j.issn.0253-2727.2016.04.001

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  3 in total

1.  [Clinical features and risk factors of vein thrombosis in 259 patients with chronic myelofiberation neoplasms].

Authors:  M J Huang; Z P He; H Y Tian; Y Wu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2017-07-14

2.  Conventional interferon-α 2b versus hydroxyurea for newly-diagnosed patients with polycythemia vera in a real world setting: a retrospective study based on 286 patients from a single center.

Authors:  Dan Liu; Zefeng Xu; Peihong Zhang; Tiejun Qin; Xiujuan Sun; Shiqiang Qu; Lijuan Pan; Jiao Ma; Wenyu Cai; Jinqin Liu; Huijun Wang; Qi Sun; Zhongxun Shi; Huijun Huang; Gang Huang; Robert Peter Gale; Bing Li; Raajit K Rampal; Zhijian Xiao
Journal:  Haematologica       Date:  2022-04-01       Impact factor: 11.047

3.  [Risk factors for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia].

Authors:  X Han; B B Bai; C J Wang; S Zhao; Y Chen
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-01-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.